These findings support a notion that it is eNOS dysfunction, not PI3K-Akt activation, that has a major role in pathogenesis of diabetic nephropathy in type 2 diabetes [18], [19]. This evidence concerns the gene AKT1 and type 2 diabetes mellitus.